Item:Q20492: Difference between revisions

Revision as of 16:53, 5 February 2024 Fire (talk \| contribs) Bureaucrats, Interface administrators, Administrators 132,457 edits ‎Created a new Item: glucagon-like peptide-1 agonist, agonist of the GLP-1 receptor used in the treatment of type 2 diabetes	Revision as of 21:54, 5 February 2024 Fire (talk \| contribs) Bureaucrats, Interface administrators, Administrators 132,457 edits ‎Created claim: subclass of (P1): anti-diabetic medication (Q20493) Newer edit →
	Property / subclass of
		anti-diabetic medication
	Property / subclass of: anti-diabetic medication / rank
		Normal rank